{"chebi_id":"5106","chebi_name":"flunisolide","chebi_synonyms":["Flunisolide anhydrous","flunisolidum","6\u03b1-fluoro-11\u03b2,21-dihydroxy-16\u03b1,17\u03b1-(isopropylidenedioxy)pregna-1,4-diene-3,20-dione","Flunisolide","flunisolida"],"diffprof_id_observed":["MTBLS2145_0002_00000029","MTBLS3750_0001_00000006"],"diffprof_id_var_observed":["MTBLS2145_0002_00000029","MTBLS3750_0001_00000006"],"inchikey":"XSFJVAJPIHIPKU-XWCQMRHXSA-N","inn_name":"flunisolidum","iupac_name":"6\u03b1-fluoro-11\u03b2,21-dihydroxy-16\u03b1,17\u03b1-(isopropylidenedioxy)pregna-1,4-diene-3,20-dione","num_study_observed":2,"reactome_ids":["R-HSA-1643685","R-HSA-2262752","R-HSA-3371497","R-HSA-5663205","R-HSA-8953897","R-HSA-9679191","R-HSA-9679506","R-HSA-9824446"],"reactome_names":["Disease","Cellular responses to stress","HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand","Infectious disease","Cellular responses to stimuli","Potential therapeutics for SARS","SARS-CoV Infections","Viral Infection Pathways"],"study_id_observed":["MTBLS2145","MTBLS3750"],"study_id_var_observed":["MTBLS2145","MTBLS3750"],"synonym_name":"Flunisolide"}